Global Synthetic Biology Market 2014-2018

Price :
Published : Jul-2014
No. of Pages : 74

Report Description

The term synthetic biology covers the designing and engineering of completely new biological parts, devices, and organisms as well as the redesigning of natural biological systems that provide improved and desirable functions. It is considered to be a form of extreme genetic engineering because it not only alters existing metabolic pathways, but also creates new ones. The engineered biological systems can be used to manipulate chemicals, fabricate materials and structures, produce energy, provide GM food, improve the efficiency of drugs and vaccines, and maintain a sustainable environment.

TechNavio’s analysts forecast the Global Synthetic Biology market will grow at a CAGR of 33.8 percent over the period 2013-2018.

Covered in this Report

The Global Synthetic Biology market can be categorized on the basis of technology into four segments: Genome Engineering. DNA Sequencing, Bioinformatics, and Biological Components and Integrated Systems.

TechNavio’s report, the Global Synthetic Biology Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Synthetic Biology market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Amyris Inc.
  • E. I. du Pont de Nemours and Co.
  • Thermo Fisher Scientific Inc.
  • Synthetic Genomics Inc.

Other Prominent Vendors

  • Algenol Biofuels Inc.
  • ATG:biosynthetics GmbH
  • Bayer AG
  • Bioneer Corp.
  • Biosearch Technologies Inc.
  • Bristol-Myers Squibb Co.
  • CBC Comprehensive Biomarker Center GmbH
  • Cobalt Technologies
  • Evolva Holdings SA
  • Exxon Mobil Corp.
  • GeneWorks Pty Ltd.
  • Genomatica Inc.
  • Gevo Inc.
  • Ginkgo Bioworks
  • Green Biologics Ltd.
  • New England Biolabs Inc.
  • OriGene Technologies Inc.
  • REG Life Sciences LLC
  • Royal DSM
  • Synthorx Inc.

Key Market Driver

  • Increased R&D in Synthetic Biology
  • For a full, detailed list, view our report.

Key Market Challenge

  • Lack of Modularized Biological Parts
  • For a full, detailed list, view our report.

Key Market Trend

  • Growing Demand for GM Crops
  • For a full, detailed list, view our report.

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report
03.1 Market Overview
03.2 Product and Service Offerings

04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05. Introduction

06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07. Market Segmentation by Technology

08. Market Segmentation by Product

09. Market Segmentation by Applications

10. Geographical Segmentation
10.1 Synthetic Biology Market in the Americas
10.1.1 Market Size and Forecast
10.2 Synthetic Biology Market in the EMEA Region
10.2.1 Market Size and Forecast
10.3 Synthetic Biology Market in the APAC Region
10.3.1 Market Size and Forecast

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Vendor Share Analysis 2013
18.3 Other Prominent Vendors

19. Key Vendor Analysis
19.1 Amyris Inc.
19.1.1 Key Facts
19.1.2 Business Description
19.1.3 Business Strategy
19.1.4 Geographical Segmentation
19.1.5 Key Developments
19.1.6 SWOT Analysis
19.1.7 Strengths
19.1.8 Weakness
19.1.9 Opportunities
19.1.10 Threats
19.2 E. I. du Pont de Nemours and Company
19.2.1 Key Facts
19.2.2 Business Description
19.2.3 Business Segmentation
19.2.4 Business Strategy
19.2.5 Revenue Segmentation
19.2.6 Revenue Comparison 2013-2011
19.2.7 Geographical Segmentation
19.2.8 Key Developments
19.2.9 SWOT Analysis
19.2.10 Strengths
19.2.11 Weakness
19.2.12 Opportunities
19.2.13 Threats
19.3 Synthetic Genomics, Inc.
19.3.1 Key Facts
19.3.2 Business Overview/ Description
19.3.3 Business Strategy
19.3.4 Key Information
19.3.5 SWOT Analysis
19.3.6 Strengths
19.3.7 Weakness
19.3.8 Opportunities
19.3.9 Threats
19.4 Thermo Fisher Scientific Inc.
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation
19.4.4 Revenue Segmentation by Business
19.4.5 Revenue Segmentation by Products
19.4.6 Sales by Geographical Segmentation
19.4.7 Business Strategy
19.4.8 Key Information
19.4.9 SWOT Analysis
19.4.10 Strengths
19.4.11 Weaknesses
19.4.12 Opportunities
19.4.13 Threats

20. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology
Exhibit 2: Global Synthetic Biology Market 2013-2018 (US$ million)
Exhibit 3: Global Synthetic Biology Market Segmentation by Technology
Exhibit 4: Global Synthetic Biology Market Segmentation by Technology 2013
Exhibit 5: Global Synthetic Biology Market Segmentation by Product
Exhibit 6: Global Synthetic Biology Market Segmentation by Applications
Exhibit 7: Global Synthetic Biology Market Segmentation by Applications 2013
Exhibit 8: Global Synthetic Biology Market by Geographical Segmentation 2013
Exhibit 9: Synthetic Biology Market in the Americas 2013-2018 (US$ million)
Exhibit 10: Synthetic Biology Market in the EMEA Region 2013-2018 (US$ million)
Exhibit 11: Synthetic Biology Market in the APAC Region 2013-2018 (US$ million)
Exhibit 12: Number of Entities Conducting Research in the Global Synthetic Biology Market 2013
Exhibit 13: Amyris Inc.: Segmentation by Geography 2013
Exhibit 14: Amyris Inc.: Revenue Comparison by Geographical Segmentation 2013-2011 (US$ million)
Exhibit 15: Business Segmentation of DuPont: 2013
Exhibit 16: Revenue Segmentation of DuPont 2013
Exhibit 17: DuPont:Revenue Comparison by business segments for 2013-2011(US$ million)
Exhibit 18: DuPont by Geographical Segmentation 2013
Exhibit 19: DuPont Revenue Comparison by Geography segments for 2013-2011 (US$ million)
Exhibit 20: Business Segmentation of Thermo Fisher Scientific Inc.
Exhibit 21: Revenue by Business Segments of Thermo Fisher Scientific Inc. 2013
Exhibit 22: Revenue by Products of Thermo Fisher Scientific Inc. 2013
Exhibit 23: Sales by Geographical Segmentation of Thermo Fisher Scientific Inc. 2013

Press Release

TechNavio Announces the Publication of its Research Report - Global Synthetic Biology Market 2014-2018

TechNavio recognizes the following companies as the key players in the Global Synthetic Biology Market : Amyris Inc., E. I. du Pont de Nemours and Co., Thermo Fisher Scientific Inc., Synthetic Genomics Inc., Algenol Biofuels Inc., ATG:biosynthetics GmbH, Bayer AG, Bioneer Corp., Biosearch Technologies Inc., Bristol-Myers Squibb Co., CBC Comprehensive Biomarker Center GmbH, Cobalt Technologies, Evolva Holdings SA, Exxon Mobil Corp., GeneWorks Pty Ltd., Genomatica Inc., Gevo Inc., Ginkgo Bioworks, Green Biologics Ltd., New England Biolabs Inc., OriGene Technologies Inc., REG Life Sciences LLC, Royal DSM, Synthorx Inc.

Commenting on the report, an analyst from TechNavio’s team said: “There is growing demand for GM crops in the Agriculture industry across the world. Synthetic biology can also be used to develop crops with desirable traits such as salt-tolerance, drought-tolerance, and pest-resistance. The use of synthetic biology technologies facilitates the designing of GM crops with entirely new metabolic pathways, physiological traits, and developmental control strategies. The need to improve crops is now increasing as plants are not only considered as food, but also as a source of renewable feedstocks. This trend is expected to increase growth in the Global Synthetic Biology market over the forecast period ”

According to the report, the growth of the Global Synthetic Biology market is driven by several factors. One of the main drivers in this market is increased R&D in synthetic biology. As synthetic biology enables the development of innovative products through gene manipulation, vendors and various other research organizations are increasingly investing in R&D, so that they can offer new products in the market.

Further, the report states that one of the major challenges in the market is the lack of modularized biological parts. Lack of standardization and modularization of synthesized biological parts causes unpredictability in their function that poses a risk of the crash of the biological circuitry. Other major challenges in the market are ethical, biosafety, and biosecurity concerns.

The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Filed in: Biotechnology
Publisher : Infiniti Research Limited
More Reports
Title Price Buy Now

Global Cancer Biomarkers Market 2015-2019

Biomarkers are molecules present in the blood, other body fluids such as serum, urine, or in tissue that are indicators of a disease or abnormal conditions. Biomarkers are mostly used as diagnostic tools. Biomarkers help in identifying potential drug failures in initial stages, leading to savings in time and costs. Biomarkers are becoming an essential part of the drug discovery process. Cancer Biomarkers are proteins or metabolites indicative of tumor state and progression characteristics. They are non-invasive, enable high speed cancer diagnosis and also enhance early cancer detection and screening. The best example of a cancer biomarker is that of prostate specific antigen. PSA is measured in the blood to screen for and monitor treatment for prostate cancer. PSA, as a biomarker helps the......

Global Bio-detection Market 2014-2018

Bio-detection has emerged as a solution to the public and governments. With an increase in bio-terrorism, the occurrence of illness and deaths is very frequent. This event is caused by the airborne chemicals or pathogens that are released by a terrorist or a group of people or even by an individual for a motive. These pathogens can be detected by a system called bio-detection, which signals the entry or the existence of a virus. The increasing attacks have brought a major concern to the public as well as governments. Attacks such as the 2001 Anthrax scare, the 2003 severe acute respiratory syndrome (SARS), the 2004 Ricin letters, the 2009 H1N1, and the 2014 Ebola outbreaks have driven governments to increase their bio-surveillance budgets. TechNavio's analysts forecast the Global Bio-de......

Global qPCR and dPCR Market 2015-2019

qPCR (Real-time Polymerase Chain Reaction) and dPCR (Digital Polymerase Chain Reaction) are the advanced PCR technologies that provide higher accuracy and reproducibility in nucleic acids amplification and analysis. qPCR allows amplification and quantification of a targeted DNA molecule in real-time. While dPCR is an advanced PCR that allows direct quantification and amplification of nucleic acids including RNA, DNA, cDNA, methylated DNA. It does not rely on the number of amplification cycles to measure the initial sample amount and provides absolute quantification of nucleic acid. qPCR and dPCR need a small amount of sample and provide higher accuracy, sensitivity, and efficiency than conventional PCR. These technologies are widely used in various research and diagnostic applications such......

Global Gene Expression Market 2015-2019

Gene expression is the biological process where genetic information is used for the synthesis of a functional gene product, either RNA or protein. Gene expression products allow researchers to study gene expression and its impact on cell function. Researchers use gene expression profiling and analysis for various applications in the areas of drug discovery and development, clinical diagnostics, and other research purposes. Advanced PCR, NGS, and DNA microarray technology allow profiling and analysis of thousands of genes in a very short period with great accuracy and reproducibility. TechNavio's analysts forecast the Global Gene Expression market to grow at a CAGR of 11.12 percent over the period 2014-2019. Covered in this Report This report covers the present scenario and the gro......

Global Prenatal and Newborn Genetic Testing Market 2015-2019

Prenatal and newborn genetic testing involves genetic testing before and after birth. Prenatal testing helps detect changes in the fetus before birth. It can reduce a couple's uncertainty or help them decide whether to abort a pregnancy in case of conditions such as Down syndrome, trisomy 18, or an open neural tube defect. The procedure includes two blood tests: one in the first trimester and the next in the second trimester. On the other hand, newborn genetic testing is done just after birth to identify genetic disorders. TechNavio's analysts forecast the Global Prenatal and Newborn Genetic Testing market to grow at a CAGR of 31.91 percent over the period 2014-2019. Covered in this Report This report covers the present scenario and the growth prospects of the Global Prenatal and Ne......

Global Microarray market 2015-2019

Microarray technology is used for studying the expression of biological materials such as DNA, RNA, small portions of tissue, or protein by immobilizing them onto a solid support such as a glass slide or silicon thin-film. The microarray analyzes large amounts of biological material using HTS miniaturized, multiplexed, and parallel processing and detection methods for a limited time with high accuracy and efficiency. Microarrays are developed by robotic machines that arrange small amounts of hundreds of biomaterial on a single slide. There are various types of microarray, including chemical compound, cellular, DNA, protein, RNA, and tissue microarrays and LOC. The technology has a broad range of applications such as in the genomic and proteomic studies for drug discovery and development, c......

Global Transfection Technologies Market 2015-2019

Transfection technology is used for the introduction of nucleic acids into desired cells. The process enables the expression of desired proteins in efficient cells. A stable transfection enables the integration of this foreign nucleic acid into the cellular DNA resulting in the expression of the desired proteins in cell lines. The process, which can be accomplished by various physical, chemical, or viral methods, can be used for potential applications such as gene therapy, protein production, and drug discovery. TechNavio's analysts forecast the Global Transfection Technologies market to grow at a CAGR of 8.71 percent over the period 2014-2019. Covered in this Report This report covers the present scenario and the growth prospects and future prospects of the Global Transfection Te......

Global Regenerative Medicine Market 2015-2019

Regenerative medicine deals with the process of using therapeutically induced or laboratory-grown human tissue to treat injured or diseased human cells, tissues, or organs. It focuses on repairing, replacing, or regenerating damaged cells, and thus offers a paradigm shift in healthcare treatment. The three main technologies used in regenerative medicine are small molecules and biologics, cell therapy, and gene therapy. Small molecules and biologics help in the regeneration of diseased cells and tissues. Whereas cell therapy helps in treating the functioning of the existing cells, gene therapy helps in the correction of defective genes of the body. TechNavio's analysts forecast the Global Regenerative Medicine market to grow at a CAGR of 20.16 percent over the period 2014-2019. Covere......

Global Human Growth Hormone Market 2015-2019

Growth hormone is a proteinaceous hormone consisting of 191 amino acid residues and is secreted by the anterior part of the pituitary gland. In children and adolescents, growth hormones are produced and secreted in high levels and promote linear growth. However, as an individual reaches the adult stage, its level starts declining and primarily perform anabolic functions. The direct activity of a human growth hormone, exerted via its interaction with the human growth hormone receptor, includes metabolic and anti-insulin activities. TechNavio's analysts forecast the Global Human Growth Hormone market to grow at a  CAGR of 4.22 percent over the period 2014-2019. Covered in this Report This report covers the present scenario and the growth prospects of the Global Human Growth Hormone......

Global miRNA Market 2015-2019

miRNAs are single-stranded, small, non-coding RNA molecules that regulate gene expression at the translation level. They play a vital role in research, diagnostics, and therapeutics to study expression of genes and to control diseases by gene silencing. They interact with mRNA molecules and regulate expression of genes by mRNA cleavage, translational repression, and deadenylation. They are generally 17-27 nucleotides long and regulate post-transcriptional mRNA expression by binding to the 3' untranslated region of the mRNA sequence, which results in translational suppression and gene silencing. miRNAs are involved in a wide range of biological processes, including apoptosis, cell cycle control, and several developmental processes such as stem cell differentiation, hypoxia, hematopoiesis, n......